| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |